Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era
Active, not recruiting
- Conditions
- Axillary Ultrasound
- Registration Number
- NCT06038110
- Lead Sponsor
- KK Women's and Children's Hospital
- Brief Summary
The investigators aimed to determine if axillary ultrasound can reliably distinguish between patients with limited or high nodal burden, so that the patients with limited nodal burden can potentially avoid chemotherapy and instead receive upfront surgery followed by gene assay testing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
- breast cancer patients with T1-3, HR-positive and HER2-negative disease.
- aged≥ 50 years old
- had axillary ultrasound prior to operation
- axillary lymph node dissection
Exclusion Criteria
- Patients with neoadjuvant chemotherapy
- bilateral cancers
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the number of abnormal nodes on ultrasound from the date of diagnosis to the date of surgery, up to 12 weeks the number of abnormal nodes on ultrasound which was done at the time of diagnosis will be measured
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
KK Women's and Children's Hospital
🇸🇬Singapore, Singapore